Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines

Cisplatin is one of the major drugs used in oral cancer treatments, but its usage can be limited by acquired drug resistance. In this study, we established three cisplatin-resistant oral squamous cell carcinoma (OSCC) cell lines and characterized them using cell viability assays, qPCR, Western blott...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyeong Sim, Kim, Young-Kyun, Yun, Pil-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627081/
https://www.ncbi.nlm.nih.gov/pubmed/31234332
http://dx.doi.org/10.3390/ijms20123034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627081/
https://www.ncbi.nlm.nih.gov/pubmed/31234332
http://dx.doi.org/10.3390/ijms20123034

Ejemplares similares